Phase I study of monoclonal antibody-ricin A chain immunotoxin XomaZyme-791 in patients with metastatic colon cancer.
Year: 1989
Type: article
Study design: Clinical Trial
Source: PubMed
Authors: V S Byers, R Rodvien, K Grant, L G Durrant, K H Hudson, R W Baldwin, P J Scannon
Institution: XOMA (United States)
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2167649892
